Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Positron emission tomography, radiopharmaceuticals

Sharma V, Piwnica-Worms D (2005) Monitoring Multidrug Resistance P-Glycoprotein Drug Transport Activity with Single-Photon-Emission Computed Tomography and Positron Emission Tomography Radiopharmaceuticals. 252 155-178 Shinkai S, see Ishi-i T (2005) 258 119-160... [Pg.205]

Monitoring Multidrug Resistance P-Glycoprotein Drug Transport Activity with Single-Photon Emission Computed Tomography and Positron Emission Tomography Radiopharmaceuticals... [Pg.155]

In 2003 LJngstrOm and Samuelsson described the synthesis of a radiopharmaceutical for PET (positron emission tomography) using a microwave-assisted Stille reaction [25]. l-(2 -Deoxy-2 -fluoro- 6-D-arabinofuranosyl)-... [Pg.159]

A specialized application of microwave-assisted organic synthesis involves the preparation of radiopharmaceuticals labeled with short-lived radionuclides, particularly for use in positron emission tomography [70-72]. This represented an excellent application of microwave technology, where the products must be prepared quickly and in high radiochemical yield, on a small scale. [Pg.56]

Nuclear medicine is used chiefly in medical diagnosis. A radiopharmaceutical—a relatively harmless compound with a low dose of radiation— is swallowed or injected into the patient and tracked through the bloodstream by instruments such as a PET (positron emission tomography) camera. The nuclear physician can use the results to create a... [Pg.129]

Stocklin G, Pike VW (eds) (1993) Radiopharmaceuticals for positron emission tomography. Cox PH (series ed) Development in nuclear medicine, vol 24, Klimder Academic Publishers, Dordrecht... [Pg.251]

The next two chapters are dedicated to radiopharmaceutical contrast agents starting with a detailed description of the chemistry of p -emitting compounds based on fluorine-18. Particular emphasis is laid on the different radiolabeled precursors and their suitability for the rapid synthesis of compounds useful for positron emission tomography. [Pg.299]

G. Stocklin, V.W. Pike, Radiopharmaceuticals for Positron Emission Tomography, Kluwer Academic Publishers, Dordrecht - Boston - London, (1993). [Pg.50]

P.H. Elsinga, Radiopharmaceutical chemistry for positron emission tomography. Methods 27 (2002) 208-217. [Pg.52]

See other pages where Positron emission tomography, radiopharmaceuticals is mentioned: [Pg.265]    [Pg.226]    [Pg.308]    [Pg.321]    [Pg.234]    [Pg.284]    [Pg.198]    [Pg.308]    [Pg.215]    [Pg.195]    [Pg.242]    [Pg.258]    [Pg.258]    [Pg.202]    [Pg.318]    [Pg.352]    [Pg.265]    [Pg.226]    [Pg.308]    [Pg.321]    [Pg.234]    [Pg.284]    [Pg.198]    [Pg.308]    [Pg.215]    [Pg.195]    [Pg.242]    [Pg.258]    [Pg.258]    [Pg.202]    [Pg.318]    [Pg.352]    [Pg.324]    [Pg.321]    [Pg.1126]    [Pg.262]    [Pg.82]    [Pg.126]    [Pg.885]    [Pg.132]    [Pg.204]    [Pg.246]    [Pg.222]    [Pg.189]    [Pg.201]    [Pg.204]    [Pg.260]    [Pg.308]    [Pg.4]    [Pg.86]    [Pg.90]    [Pg.1126]   
See also in sourсe #XX -- [ Pg.692 ]



SEARCH



Emission tomography

Positron

Positron Emission Tomography

Positron emission

Radiopharmaceutical

© 2024 chempedia.info